<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Community-acquired pneumonia (adults) — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Community-acquired pneumonia (adults)</h1>
        <div class="sub">Adult CAP: confirm likely pneumonia clinically, assess severity (CRB‑65 + judgement), start antibiotics promptly, and decide community vs hospital/SDEC.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑10</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points (NICE-aligned)</strong>
                <ul>
                  <li>Use <strong>clinical judgement plus CRB‑65</strong> to stratify severity in adults with suspected community-acquired pneumonia (CAP).</li>
                  <li>CAP is higher risk when there is <strong>hypoxia</strong>, <strong>sepsis</strong>, <strong>confusion</strong>, <strong>hypotension</strong>, or significant comorbidity/frailty.</li>
                  <li>Start antibiotics <strong>as soon as a diagnosis is established</strong>. In hospital, NICE targets starting within <strong>4 hours</strong> of presentation.</li>
                  <li>Microbiological testing is generally reserved for <strong>moderate/high severity</strong> or when there are additional indications (e.g. suspected sepsis, risk factors for legionella).</li>
                  <li>Follow-up CXR is <strong>not routine</strong> after inpatient pneumonia, but is considered at ~6 weeks for people with <strong>lung cancer risk factors</strong> (e.g. smokers, age &gt;50), persisting symptoms, or weight loss.</li>
                </ul>
              </div>

              <div class="callout warn">
                <strong>Antibiotics: what this draft does (and does not) do</strong>
                <ul>
                  <li>This page intentionally avoids hard-coding a full antibiotic table because DGRefHelp needs to align to <strong>D&amp;G antimicrobial guidance</strong> (formulary/resistance vary).</li>
                  <li>It does include the <strong>decision structure</strong> and the <strong>most useful referral triage metrics</strong>.</li>
                </ul>
              </div>

              <h4>Comparator sources used for the draft</h4>
              <ul>
                <li>NICE NG250 (2025): pneumonia diagnosis, severity assessment, antibiotic principles, investigations, reassessment and follow-up imaging advice.</li>
              </ul>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">
            <div id="draftText" class="section">
              <h3>Community-acquired pneumonia (CAP) — adults (primary care)</h3>

              <h4>Definition / scope</h4>
              <ul>
                <li>Acute illness (typically &lt;21 days) with symptoms/signs consistent with pneumonia, acquired outside hospital.</li>
                <li>Applies to adults; separate pathways needed for children, pregnancy, and immunocompromise.</li>
              </ul>

              <h4>Immediate red flags (same-day assessment / ED)</h4>
              <ul>
                <li><strong>SpO2 low</strong> (especially &lt;92% on air, or any cyanosis) or signs of respiratory failure.</li>
                <li><strong>Sepsis concern</strong>: hypotension, new confusion, lactate concern, mottling, not passing urine, rapidly deteriorating.</li>
                <li><strong>CRB‑65 high severity</strong> (score 3–4).</li>
                <li><strong>Unable to maintain oral intake</strong>, repeated vomiting, or cannot cope at home.</li>
                <li><strong>Alternative diagnosis suspected</strong> that is time-critical (e.g. PE, ACS, pneumothorax), or diagnostic uncertainty in a sick patient.</li>
              </ul>

              <h4>Assess severity (CRB‑65 + judgement)</h4>
              <ul>
                <li><strong>CRB‑65 (1 point each):</strong>
                  <ul>
                    <li><strong>C</strong>onfusion (new disorientation)</li>
                    <li><strong>R</strong>espiratory rate ≥30/min</li>
                    <li><strong>B</strong>lood pressure: systolic &lt;90 or diastolic ≤60</li>
                    <li>Age ≥<strong>65</strong></li>
                  </ul>
                </li>
                <li><strong>Interpretation (typical):</strong>
                  <ul>
                    <li>Score 0: usually low severity → consider community management if safe.</li>
                    <li>Score 1–2: moderate severity → consider hospital/SDEC/virtual-ward depending on clinical judgement and support.</li>
                    <li>Score 3–4: high severity → urgent hospital assessment/admission.</li>
                  </ul>
                </li>
                <li><strong>Upgrade risk</strong> even with low CRB‑65 if: significant hypoxia, frailty, immunosuppression, major comorbidity (COPD/heart failure/CKD), or poor social support.</li>
              </ul>

              <h4>Assessment (primary care)</h4>
              <ul>
                <li><strong>History:</strong> fever/rigors, cough, sputum, pleuritic pain, breathlessness, haemoptysis, duration, sick contacts/travel, aspiration risk; comorbidities and immunosuppression.</li>
                <li><strong>Observations:</strong> HR, BP, RR, Temp, <strong>SpO2 on air</strong> (document if on oxygen), mental state.</li>
                <li><strong>Examination:</strong> work of breathing, focal chest signs, signs of heart failure/volume overload; calf swelling/pain if PE risk.</li>
                <li><strong>Investigations (community):</strong> none routinely mandated; consider CXR if diagnosis uncertain, severe symptoms, poor response, or cancer risk features.</li>
              </ul>

              <h4>Initial management (community)</h4>
              <ul>
                <li><strong>Start antibiotics</strong> when clinical diagnosis of CAP is made (do not delay unnecessarily).</li>
                <li><strong>Antibiotic choice:</strong> use <strong>local antimicrobial guidance</strong> (typical pattern: amoxicillin for low severity; doxycycline/clarithromycin if penicillin allergy; broader cover for comorbidity/moderate severity — local policy).</li>
                <li><strong>Safety-net:</strong> seek urgent help if worsening breathlessness, persistent fever, confusion, unable to eat/drink, or not improving within ~3 days.</li>
                <li>Consider smoking cessation advice and review pneumococcal/flu vaccination status opportunistically.</li>
              </ul>

              <h4>Who to refer / admit</h4>
              <ul>
                <li><strong>ED / acute medical assessment:</strong> high severity (CRB‑65 3–4), hypoxia, sepsis concern, inability to cope, significant diagnostic uncertainty.</li>
                <li><strong>Consider SDEC / hospital-at-home / virtual ward</strong> (if available): moderate severity (CRB‑65 1–2) with stable obs and support, or borderline cases needing CXR/bloods/short interval review.</li>
                <li><strong>Routine respiratory</strong> is usually not appropriate for acute CAP unless complications or persistent symptoms suggest alternative diagnosis (local pathway decision).</li>
              </ul>

              <h4>Who not to refer (usually)</h4>
              <ul>
                <li>Low severity CAP (CRB‑65 0) with normal/acceptable obs, able to cope at home, and clear safety-netting.</li>
              </ul>

              <h4>Referral letter / triage metrics (if referring)</h4>
              <ul>
                <li>CRB‑65 components (explicitly state confusion? RR? BP? age?), and your overall severity judgement.</li>
                <li>SpO2 on air (and whether on oxygen), RR, HR, BP, Temp.</li>
                <li>Duration of illness; main symptoms; pleuritic pain; haemoptysis.</li>
                <li>Comorbidities, frailty, immunosuppression; aspiration risk.</li>
                <li>Any tests done (CXR if obtained; ECG if chest pain; swabs if relevant).</li>
                <li>Antibiotics given (drug + dose + start time) and response so far.</li>
                <li>Home situation / support / ability to manage oral meds/fluids.</li>
              </ul>

              <div class="callout warn">
                <strong>Local agreement needed (D&amp;G)</strong>
                <ul>
                  <li>[ ] Agree local SpO2 thresholds/approach for community vs ED for suspected CAP (especially in COPD/hypercapnic risk).</li>
                  <li>[ ] Agree what constitutes "moderate severity" handling locally (SDEC vs ED vs virtual ward) for CRB‑65 1–2.</li>
                  <li>[ ] Confirm local first-line antibiotic regimens by severity group (and penicillin allergy alternatives), plus typical durations.</li>
                  <li>[ ] Agree local advice on when to request CXR from primary care for CAP (vs treat empirically).</li>
                </ul>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ul>
                <li>NICE. <em>Pneumonia: diagnosis and management (NG250)</em>. Published 2 Sep 2025. Accessed 2026‑02‑10. https://www.nice.org.uk/guidance/ng250</li>
              </ul>
              <p class="small">Draft note: antibiotic choice/duration must be checked against local antimicrobial guidance; this page provides the triage structure + documentation prompts.</p>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
